{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,14]],"date-time":"2025-05-14T07:03:19Z","timestamp":1747206199011,"version":"3.40.5"},"reference-count":13,"publisher":"Informa UK Limited","license":[{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/3.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["DMSO"],"DOI":"10.2147\/dmso.s429114","type":"journal-article","created":{"date-parts":[[2023,12,28]],"date-time":"2023-12-28T08:10:08Z","timestamp":1703751008000},"page":"4263-4268","source":"Crossref","is-referenced-by-count":0,"title":["Randomized, Double-Blind, Placebo-Controlled, Phase I, Dose- Escalation Study to Evaluate the Tolerance, Pharmacokinetics, Pharmacodynamics and Immunogenicity of PEGylated Urate Oxidase for Injection in Healthy Adults and Hyperuricemia Volunteers: Study Protocol"],"prefix":"10.2147","volume":"Volume 16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8161-536X","authenticated-orcid":true,"given":"Feifei","family":"Sun","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chenjing","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yi","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pingping","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yaozhong","family":"Cao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiahui","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xin","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xin","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yao","family":"Fu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3980-8133","authenticated-orcid":true,"given":"Yu","family":"Cao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2023,12]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1016\/j.amjmed.2011.09.033","volume":"125","author":"Zhu","year":"2012","journal-title":"Am J Med"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"10","DOI":"10.3111\/13696998.2010.540874","volume":"14","author":"Edwards","year":"2011","journal-title":"J Med Econ"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1177\/2042098617727714","volume":"8","author":"Guttmann","year":"2017","journal-title":"Ther Adv Drug Saf"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"2193","DOI":"10.1093\/molbev\/msw116","volume":"33","author":"Tan","year":"2016","journal-title":"Mol Biol Evol"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.ejim.2015.11.026","volume":"29","author":"Kanbay","year":"2016","journal-title":"Eur J Intern Med"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"9221","DOI":"10.3390\/ijms22179221","volume":"22","author":"Yanai","year":"2021","journal-title":"Int J Mol Sci"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1186\/s12891-019-2519-y","volume":"20","author":"Towiwat","year":"2019","journal-title":"BMC Musculoskelet Disord"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1038\/nrd3349","volume":"10","author":"Schlesinger","year":"2011","journal-title":"Nat Rev Drug Discov"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.addr.2007.06.011","volume":"60","author":"Sherman","year":"2008","journal-title":"Adv Drug Deliv Rev"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"S31","DOI":"10.1016\/j.semarthrit.2020.04.011","volume":"50","author":"Schlesinger","year":"2020","journal-title":"Semin Arthritis Rheum"},{"key":"ref11","unstructured":"Krystexxa prescribing information; 2012. Available from: https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2012\/125293s034lbl.pdf. Accessed December 22, 2023."},{"key":"ref12","doi-asserted-by":"crossref","unstructured":"World Medical A. World medical association declaration of Helsinki: ethical principles for medical research involving human subjects. JAMA. 2013;310(20):2191\u20132194. doi:10.1001\/jama.2013.281053","DOI":"10.1001\/jama.2013.281053"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1254\/fpj.138.205","volume":"138","author":"Takezawa","year":"2011","journal-title":"Nihon Yakurigaku Zasshi"}],"container-title":["Diabetes, Metabolic Syndrome and Obesity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.dovepress.com\/getfile.php?fileID=95626","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.dovepress.com\/getfile.php?fileID=95626","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,12,28]],"date-time":"2023-12-28T08:10:14Z","timestamp":1703751014000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.dovepress.com\/randomized-double-blind-placebo-controlled-phase-i-dose--escalation-st-peer-reviewed-fulltext-article-DMSO"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12]]},"references-count":13,"URL":"https:\/\/doi.org\/10.2147\/dmso.s429114","relation":{},"ISSN":["1178-7007"],"issn-type":[{"type":"electronic","value":"1178-7007"}],"subject":[],"published":{"date-parts":[[2023,12]]}}}